A specific lot of blood pressure medication has been recalled after a bottle from that lot was found to be mislabeled, according to a Food and Drug Administration statement.
The bottle was supposed to contain Hydrochlorothiazide Tablets USP 12.5 mg — a medication used to treat high blood pressure. Instead, they contained Spironolactone Tablets USP 25 mg — used to treat congestive heart failure, cirrhosis of the liver and other ailments.
The FDA says that the effects of mixing up the medications depends on the individual, but can range from “limited” to “life-threatening.”
